We Won’t Do Everything
45:39–46:26 · 47s
Lance sets boundaries—no chase for every vertical like ED—focusing instead on areas where Transcend can be best-in-class with biomarker-driven protocols and a possible rebrand.
45:39–46:26 · 47s
Lance sets boundaries—no chase for every vertical like ED—focusing instead on areas where Transcend can be best-in-class with biomarker-driven protocols and a possible rebrand.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.